Statement on Health Canada’s pilot to reduce regulatory barriers to pediatric standard of care clinical trials
On October 14, 2026, Health Canada announced a pilot program to reduce barriers for select academic-led peediatric standard of care…
On October 14, 2026, Health Canada announced a pilot program to reduce barriers for select academic-led peediatric standard of care…
Cell and gene therapies are rapidly transforming the pediatric rare disease treatment landscape and are offering new possibilities for conditions…
Canada is entering a new era in pediatric rare disease research, driven by advances in precision medicine and novel, innovative…
RareKids-CAN’s Clinical Trial Navigator network supports pediatric rare disease clinical trial readiness across Canada by helping connect institutions, investigators, and…
RareKids-CAN’s Clinical Trial Navigators help strengthen pediatric rare disease clinical trial capacity across Canada by serving as a local contact…
RareKids-CAN’s Clinical Trial Navigators help strengthen pediatric rare disease clinical trial readiness across Canada by supporting study start-up, facilitating collaboration…
Clinical trials can play a critical role in improving access to treatments and advancing care for children living with rare…
RareKids-CAN, Canada’s pediatric rare disease clinical trials and treatment network funded by the Canadian Institutes for Health Research, supports Bill…
Patients and families are central to RareKids-CAN and our work. As part of our commitment to Strategic Priority 1: Enhancing…